IN8BIO, Inc. funding

IN8BIO, Inc., a biotechnology company based in New York, NY, filed a Form D with the SEC on December 30, 2025 and reported $20.1M raised of a $40.2M offering.

Amount raised$20.1M

Offering size$40.2M

Filed with the SECDecember 30, 2025

First saleDecember 22, 2025

IndustryBiotechnology

SecuritiesEquity, Options or warrants, Security to be acquired on exercise

LocationNew York, NY

FoundedMore than 5 years ago

Entity typeCorporation

Investors so far17

Minimum investment—

Revenue rangeDecline to Disclose

View the original Form D on SEC EDGAR ↗ · All rounds filed Dec 30

Other health care rounds in New York

Precision Neuroscience Corp$250M · Sep 28Other Health Care Click Therapeutics, Inc.$50M · Oct 1Other Health Care Amani Therapeutics, Inc.$35M · Oct 1Other Health Care Atmos Clinic, Inc.$6M · Oct 8Other Health Care CAD Therapeutics, Inc.$4M · Oct 2Biotechnology PreciseDx, Inc.$3.7M · Oct 7Other Health Care Hypercell Technologies Inc.$3M · Oct 14Biotechnology AmorSui Inc.$2.7M · Sep 23Other Health Care